Skip to content

Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients

Effect of Evidence-Based Nursing Intervention Under Quantitative Evaluation Strategy on Psychological Resilience and Illness Perception in Lung Cancer Patients Undergoing Chemotherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07049250
Enrollment
142
Registered
2025-07-03
Start date
2024-03-01
Completion date
2025-03-01
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Chemotherapy, Psychological Resilience, Illness Perception, Evidence-Based Nursing, Quantitative Evaluation Strategy

Brief summary

This study investigates the effect of an evidence-based nursing intervention, guided by a quantitative evaluation strategy, on psychological resilience and illness perception in lung cancer patients undergoing chemotherapy. Patients were randomized to receive either the specialized nursing intervention or routine nursing care, with outcomes assessed at baseline and 3 months post-intervention.

Detailed description

Lung cancer patients undergoing chemotherapy often experience significant physical and psychological distress. Conventional nursing may not adequately address these multifaceted needs. Evidence-based nursing (EBN) integrates research evidence, clinical expertise, and patient preferences. This study evaluated an EBN intervention model guided by a quantitative evaluation strategy, which involves multidisciplinary risk assessment, tailored interventions including psychological support, cognitive restructuring, and complication prevention. The study aimed to determine if this model could improve psychological resilience, illness perception, coping styles, and reduce chemotherapy-related complications in lung cancer patients compared to routine nursing care. A total of 142 patients were randomized. The intervention group received a comprehensive EBN program including risk stratification, psychological/cognitive interventions (e.g., cognitive-behavioral techniques, peer mentoring, family counseling), systematic complication prevention (e.g., prophylactic antiemetics, dietary guidance, infection control), and sleep optimization. The control group received standard disease education, exercise guidance, and medication adherence counseling. Outcomes were measured at baseline and 3 months post-intervention.

Interventions

BEHAVIORALEvidence-Based Nursing Intervention under Quantitative Evaluation Strategy

A multifaceted nursing program incorporating comprehensive risk assessment, dynamic risk stratification, psychological and cognitive interventions (including cognitive-behavioral techniques, peer mentoring, family counseling), systematic complication prevention strategies (including prophylactic antiemetics, dietary guidance, infection control), and sleep optimization protocols.

Standard disease education on chemotherapy side effects and self-management, personalized exercise guidance, and medication adherence counseling. Delivered in 30-minute sessions twice weekly for two months.

Sponsors

The First Hospital of Hebei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of lung cancer confirmed according to the Chinese Quality Control Indicators for Standardized Diagnosis and Treatment of Primary Lung Cancer (2022) through both imaging and histopathological examination. * TNM staging determined using the 8th edition AJCC/UICC classification system. * Scheduled to receive chemotherapy with an expected survival exceeding one year. * Demonstrated normal cognitive and communication abilities as assessed by standardized neuropsychological tests. * Provided written informed consent prior to enrollment.

Exclusion criteria

* Pre-existing neurological disorders. * Significant organ dysfunction (defined as Child-Pugh class B/C for liver function or eGFR \<30 mL/min/1.73m² for renal function). * Active infectious diseases. * Contraindications to chemotherapy. * Concurrent radiotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Change in Psychological Resilience ScoreBaseline and 3 months post-intervention.Psychological resilience assessed using the 25-item Resilience Scale. Scores range from 0 to 100, with higher scores indicating better psychological resilience. The scale measures optimism, resilience, and strength subdomains.

Secondary

MeasureTime frameDescription
Change in Illness PerceptionBaseline and 3 months post-intervention.Illness perception assessed using the Brief Illness Perception Questionnaire (B-IPQ). This evaluates emotional, cognitive, and comprehension domains, with each item scored from 0 to 10. Higher scores in relevant domains indicate more positive or accurate illness perception.
Change in Coping StylesBaseline and 3 months post-intervention.Coping styles measured by the Simplified Coping Style Questionnaire (SCSQ) to distinguish between active and passive coping strategies. Higher scores for active coping and lower scores for passive coping are generally considered favorable.
Incidence of Chemotherapy-Related ComplicationsAssessed throughout the 3-month post-intervention period.Occurrence of chemotherapy-related complications including gastrointestinal reactions, pulmonary infections, hepatorenal toxicity, bone marrow suppression, and phlebitis. Assessed as percentage of patients experiencing each complication.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026